1
|
Ma J and Jemal A: Breast cancer metastasis
and drug resistance. Springer; New York, NY: pp. 1–18. 2013
|
2
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Bartsch R, Ziebermayr R, Zielinski CC and
Steger GG: Triple-negative breast cancer. Wien Med Wochenschr.
160:174–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bianchini G, Balko JM, Mayer IA, Sanders
ME and Gianni L: Triple-negative breast cancer: Challenges and
opportunities of a heterogeneous disease. Nat Rev Clin Oncol.
13:674–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bhan A and Mandal SS: LncRNA HOTAIR: A
master regulator of chromatin dynamics and cancer. Biochim Biophys
Acta. 1856:151–164. 2015.PubMed/NCBI
|
11
|
Zhuang R, Zhang X, Lu D, Wang J, Zhuo J,
Wei X, Ling Q, Xie H, Zheng S and Xu X: lncRNA DRHC inhibits
proliferation and invasion in hepatocellular carcinoma via
c-Myb-regulated MEK/ERK signaling. Mol Carcinog. 58:366–375. 2019.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Collina F, Aquino G, Brogna M, Cipolletta
S, Buonfanti G, De Laurentiis M, Di Bonito M, Cantile M and Botti
G: LncRNA HOTAIR up-regulation is strongly related with lymph nodes
metastasis and LAR subtype of Triple Negative Breast Cancer. J
Cancer. 10:2018–2024. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang YL, Overstreet AM, Chen MS, Wang J,
Zhao HJ, Ho PC, Smith M and Wang SC: Combined inhibition of EGFR
and c-ABL suppresses the growth of triple-negative breast cancer
growth through inhibition of HOTAIR. Oncotarget. 6:11150–11161.
2015.PubMed/NCBI
|
15
|
Ferrè F, Colantoni A and Helmer-Citterich
M: Revealing protein-lncRNA interaction. Brief Bioinform.
17:106–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA-LncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhao W, Geng D, Li S, Chen Z and Sun M:
Lnc RNA HOTAIR influences cell growth, migration, invasion, and
apoptosis via the miR-20a-5p/HMGA 2 axis in breast cancer. Cancer
Med. 7:842–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hu W, Xu W, Shi Y and Dai W: lncRNA HOTAIR
upregulates COX-2 expression to promote invasion and migration of
nasopharyngeal carcinoma by interacting with miR-101. Biochem
Biophys Res Commun. 505:1090–1096. 2018. View Article : Google Scholar : PubMed/NCBI
|